Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cholesterol Goal Attainment Rate and Its Associated Factors Among Dyslipidemic Patients on Lipid-lowering Drug Therapy in Korea (CRESCENDO)

NCT01372956 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01372956
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01372956 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cholesterol Goal Attainment Rate and Its Associated Factors Among Dyslipidemic Patients on Lipid-lowering Drug Therapy in Korea (CRESCENDO)
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
August 31, 2011
Completion date
October 31, 2011
Enrollment
4,950 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

dyslipidemia